tezosentan has been researched along with Acute Kidney Tubular Necrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Robinson, AV; Schulak, JA; Stowe, NT; Wilhelm, SM | 1 |
1 other study(ies) available for tezosentan and Acute Kidney Tubular Necrosis
Article | Year |
---|---|
The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function.
Topics: Animals; Endothelin Receptor Antagonists; Endothelin-1; Glomerular Filtration Rate; Immunohistochemistry; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Male; Pyridines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Tetrazoles; Time Factors | 2001 |